Abstract:Objective: Anesthetic preconditioning appears to be a viable strategy to treat ischemic cerebral injury. Here we investigated 1) whether the protection conferred by sevoflurane preconditioning sustains in time; 2) whether sevoflurane preconditioning diminishes mitochondrial dysfunction following cerebral ischemia; and 3) whether mitochondrial permeability transition pore plays a crucial role in the sevoflurane preconditioning.Design: Laboratory investigation.Setting: University research laboratory.Subjects: Sprague-Dawley rats.Interventions: Rats underwent 2 hrs of focal cerebral ischemia induced by middle cerebral artery occlusion. Preconditioning was elicited with sevoflurane (2.3%) for 60 mins at 24 hrs before ischemia. The involvement of mitochondrial permeability transition pore was determined with a mitochondrial permeability transition pore opener atractyloside and a specific mitochondrial permeability transition pore inhibitor cyclosporin A. In vitro study was performed on acutely isolated mitochondria subjected to calcium overload.Measurements and Main Results: Sevoflurane preconditioning significantly decreased the infarct size by 35.9% (95% confidence interval 6.5-28.4, p < .001). This reduction of injury volume was associated with a long-term improvement of neurological function according to modified neurological severity score (F = 13.6, p = .001) and sticky-tape test (F = 29.1, p < .001) for 42 days after ischemia. Furthermore, sevoflurane preconditioning markedly protected mitochondria, as indicated by preserved respiratory chain complex activities and membrane potential, lowered mitochondrial hydrogen-peroxide production, and attenuated mitochondrial permeability transition pore opening. Isolated mitochondria also demonstrated a reduced sensitivity to Ca2+-induced mitochondrial permeability transition pore opening after pre-exposure to sevoflurane in vitro (95% confidence interval 24.2-196.5, p = .006). Inhibiting mitochondrial permeability transition pore using cyclosporin A resulted in protective effects similar to those seen with sevoflurane preconditioning, whereas pharmacologically opening the mitochondrial permeability transition pore with atractyloside abrogated all the positive effects of sevoflurane preconditioning and cyclosporin A, including suppression of mitochondrial permeability transition pore opening, counteraction of mitochondria-dependent apoptotic pathway, and subsequent histological and behavioral improvements.Conclusions: Sevoflurane preconditioning protects mitochondria from cerebral ischemia/reperfusion injury and ameliorates long-term neurological deficits. Inhibition of mitochondrial permeability transition pore opening is a crucial step in mediating the neuroprotection of sevoflurane preconditioning. (Crit Care Med 2012; 40:2685-2693)

Sevoflurane preconditioning induced endogenous neurogenesis against ischemic brain injury by promoting microglial activation.

Postconditioning with Sevoflurane Protects Against Focal Cerebral Ischemia and Reperfusion Injury Via Pi3k/Akt Pathway

Sevoflurane Preconditioning Improves Mitochondrial Function And Long-Term Neurologic Sequelae After Transient Cerebral Ischemia: Role Of Mitochondrial Permeability Transition

Sevoflurane Preconditioning Protects Blood-Brain-barrier Against Brain Ischemia.

Sevoflurane Postconditioning Attenuates Reactive Astrogliosis and Glial Scar Formation after Ischemia–reperfusion Brain Injury

Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats

Sevoflurane Preconditioning Induces Neuroprotection Through Reactive Oxygen Species-Mediated Up-Regulation of Antioxidant Enzymes in Rats

Inhibition of N-myc downstream-regulated gene-2 is involved in an astrocyte-specific neuroprotection induced by sevoflurane preconditioning.

[Sevoflurane Preconditioning Induced Delayed Neuroprotection Against Focal Cerebral Ischemia in Rats].

Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation

Neuroprotection of sevoflurane against ischemia/reperfusion-induced brain injury through inhibiting GluN2A/GluN2B-PSD-95-MLK3 module

miR-15b suppression of Bcl-2 contributes to cerebral ischemic injury and is reversed by sevoflurane preconditioning.

Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase

Sevoflurane-induced delayed neuroprotection involves mitoK ATP channel opening and PKC ε activation

Sevoflurane Post-conditioning Enhanced Hippocampal Neuron Resistance to Global Cerebral Ischemia Induced by Cardiac Arrest in Rats Through PI3K/Akt Survival Pathway

Sevoflurane preconditioning inhibits brain injury in hypoxic mice

Sevoflurane preconditioning confers neuroprotection via anti-inflammatory effects.

Effect of Sevoflurane Preconditioning on Expression of Metabotropic Glutamate Receptor Type II During Focal Cerebral Ischemia-Reperfusion in Rats

Neuroprotection Induced by Sevoflurane-Delayed Post-Conditioning is Attributable to Increased Phosphorylation of Mitochondrial GSK-3β Through the PI3K/Akt Survival Pathway

Sevoflurane Preconditioning-Induced Neuroprotection is Associated with Akt Activation Via Carboxy-Terminal Modulator Protein Inhibition

Sevoflurane Postconditioning Reduces Myocardial Reperfusion Injury in Rat Isolated Hearts Via Activation of PI3K/Akt Signaling and Modulation of Bcl-2 Family Proteins.